191 related articles for article (PubMed ID: 33865425)
1. In vitro anti-bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection.
Shen X; Zhang W; Peng C; Yan J; Chen P; Jiang C; Yuan Y; Chen D; Zhu W; Yao M
Chin Med; 2021 Apr; 16(1):33. PubMed ID: 33865425
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-bactrical activity and its preliminary mechanism of action of the non-medicinal parts of Sanguisorba officinalis L. against Helicobacter pylori infection.
Chen P; Chen M; Peng C; Yan J; Shen X; Zhang W; Yuan Y; Gan G; Luo X; Zhu W; Yao M
J Ethnopharmacol; 2024 Jan; 318(Pt B):116981. PubMed ID: 37574016
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of the molecular mechanism of Sanguisorba Officinalis L. against leukopenia based on network pharmacology.
Wang L; Li H; Shen X; Zeng J; Yue L; Lin J; Yang J; Zou W; Li Y; Qin D; Wu A; Wu J
Biomed Pharmacother; 2020 Dec; 132():110934. PubMed ID: 33254437
[TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the
Jiang N; Li H; Sun Y; Zeng J; Yang F; Kantawong F; Wu J
Front Pharmacol; 2021; 12():618522. PubMed ID: 33746755
[No Abstract] [Full Text] [Related]
5. Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of
Zhang W; Sang S; Peng C; Li GQ; Ou L; Feng Z; Zou Y; Yuan Y; Yao M
Front Oncol; 2022; 12():807718. PubMed ID: 35646655
[TBL] [Abstract][Full Text] [Related]
6. Integrating Network Pharmacology Approaches to Decipher the Multi-Target Pharmacological Mechanism of Microbial Biosurfactants as Novel Green Antimicrobials against Listeriosis.
Adnan M; Siddiqui AJ; Noumi E; Hannachi S; Ashraf SA; Awadelkareem AM; Snoussi M; Badraoui R; Bardakci F; Sachidanandan M; Patel M; Patel M
Antibiotics (Basel); 2022 Dec; 12(1):. PubMed ID: 36671206
[No Abstract] [Full Text] [Related]
7.
Feng Z; Li H; Hao Y; Peng C; Ou L; Jia J; Xun M; Zou Y; Chen M; Zhang G; Yao M
Front Microbiol; 2024; 15():1355460. PubMed ID: 38440143
[TBL] [Abstract][Full Text] [Related]
8. Revealing the novel effect of Jinghua Weikang capsule against the antibiotic resistance of
Jia X; Huang Q; Lin M; Chu Y; Shi Z; Zhang X; Ye H
Front Microbiol; 2022; 13():962354. PubMed ID: 36147839
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and molecular analysis of the effects of Huangqi Jianzhong decoction on proliferation and apoptosis in GES-1 cells infected with
Hu J; He T; Liu J; Jia S; Li B; Xu W; Liao M; Guo L
Front Pharmacol; 2022; 13():1009705. PubMed ID: 36249768
[No Abstract] [Full Text] [Related]
10. Epinecidin-1 antimicrobial activity: In vitro membrane lysis and In vivo efficacy against Helicobacter pylori infection in a mouse model.
Narayana JL; Huang HN; Wu CJ; Chen JY
Biomaterials; 2015 Aug; 61():41-51. PubMed ID: 25996410
[TBL] [Abstract][Full Text] [Related]
11. Changes in cell membrane properties and phospholipid fatty acids of bacillus subtilis induced by polyphenolic extract of Sanguisorba officinalis L.
Zhu HL; Chen G; Chen SN; Wang RQ; Chen L; Xue H; Jian SP
J Food Sci; 2020 Jul; 85(7):2164-2170. PubMed ID: 32572963
[TBL] [Abstract][Full Text] [Related]
12. A Network Pharmacology Approach to Estimate the Active Ingredients and Potential Targets of Cuscutae semen in the Treatment of Osteoporosis.
Dai W; Sun Y; Zhong G
Med Sci Monit; 2020 Feb; 26():e920485. PubMed ID: 32081843
[TBL] [Abstract][Full Text] [Related]
13. Key ingredients in
Chen Y; Gan Y; Yu J; Ye X; Yu W
Front Plant Sci; 2023; 14():1154266. PubMed ID: 37077636
[TBL] [Abstract][Full Text] [Related]
14. Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-Di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cells.
Long W; Liu S; Li XX; Shen X; Zeng J; Luo JS; Li KR; Wu AG; Yu L; Qin DL; Hu GQ; Yang J; Wu JM
Pharmacol Res; 2021 Apr; 166():105491. PubMed ID: 33582247
[TBL] [Abstract][Full Text] [Related]
15. In-vitro characterisation of a novel antimicrobial agent, TNP-2092, against Helicobacter pylori clinical isolates.
Wang B; Zhao Q; Yin W; Yuan Y; Wang X; Wang YH; Wang H; Ye W; Chen S; Guo HL; Xie Y
Swiss Med Wkly; 2018; 148():w14630. PubMed ID: 30044468
[TBL] [Abstract][Full Text] [Related]
16. A colorimetric broth microdilution method for assessment of Helicobacter pylori sensitivity to antimicrobial agents.
Knezevic P; Aleksic Sabo V; Simin N; Lesjak M; Mimica-Dukic N
J Pharm Biomed Anal; 2018 Apr; 152():271-278. PubMed ID: 29448222
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of ellagic acid against Helicobacter pylori isolates from India and during infections in mice.
De R; Sarkar A; Ghosh P; Ganguly M; Karmakar BC; Saha DR; Halder A; Chowdhury A; Mukhopadhyay AK
J Antimicrob Chemother; 2018 Jun; 73(6):1595-1603. PubMed ID: 29566160
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of "Scutellaria barbata-Hedyotis diffusa" against breast cancer based on network pharmacology].
Jing XU; Feng-Qin S; Ke-Xin DU; Jia D; Dong-Yun LI
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4448-4454. PubMed ID: 33164375
[TBL] [Abstract][Full Text] [Related]
19. Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology.
Zhang SQ; Xu HB; Zhang SJ; Li XY
Med Sci Monit; 2020 May; 26():e923624. PubMed ID: 32474568
[TBL] [Abstract][Full Text] [Related]
20. Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates.
Kouitcheu Mabeku LB; Eyoum Bille B; Tepap Zemnou C; Tali Nguefack LD; Leundji H
BMC Infect Dis; 2019 Oct; 19(1):880. PubMed ID: 31640588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
